Jump to main content
Jump to site search

Issue 9, 2014
Previous Article Next Article

Personalized protein coronas: a “key” factor at the nanobiointerface

Author affiliations

Abstract

It is now well known that the primary interactions of biological entities (e.g., tissues and cells) with nanoparticles (NPs) are strongly influenced by the protein composition of the “corona” (i.e., the NP surface attached proteins). The composition of the corona strongly depends on the protein source (e.g., human plasma). Because the protein source determines the NP corona, it is reasonable to hypothesize that humans with specific disease(s) may have specific NP coronas. To test this hypothesis, we incubated two different hydrophobic/hydrophilic types of NPs (polystyrene and silica) with plasma from human subjects with different diseases and medical conditions (e.g., breast cancer, diabetes, hypercholesterolemia, rheumatism, fauvism, smoking, hemodialysis, thalassemia, hemophilia A and B, pregnancy, common cold and hypofibrinogenemia). Our results demonstrate that the type of disease has a crucial role in the protein composition of the NP corona. Based on these results, we introduce the concept of the “personalized protein corona” (PPC) as a determinant factor in nano-biomedical science. This study will help researchers rationally design experiments based on the “personalized protein corona” for clinical and biological applications.

Graphical abstract: Personalized protein coronas: a “key” factor at the nanobiointerface

Back to tab navigation

Supplementary files

Article information


Submitted
18 Apr 2014
Accepted
05 May 2014
First published
30 May 2014

Biomater. Sci., 2014,2, 1210-1221
Article type
Paper

Personalized protein coronas: a “key” factor at the nanobiointerface

M. J. Hajipour, S. Laurent, A. Aghaie, F. Rezaee and M. Mahmoudi, Biomater. Sci., 2014, 2, 1210
DOI: 10.1039/C4BM00131A

Social activity

Search articles by author

Spotlight

Advertisements